Manufacturer record
Ridley Life Sciences Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Ridley Life Sciences Pvt. Ltd (Delhi) were declared Not of Standard Quality between December 2022 and October 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: RL230004, Levetiracetam Oral Solution IP (exp Dec 2024). CDL Kolkata (CDSCO lab) found it not of standard quality: Description. Listed in the October 2023 alert.
Records by type
3 records linked to Ridley Life Sciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levetiracetam Oral Solution IP | Batch RL230004Mfg Jan 2023 · Exp Dec 2024 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2023 |
| Telmirid-40 (Telmisartan Tablets I.P. 40 mg) | Batch RT220651Mfg Aug 2022 · Exp Jul 2024 | DissolutionDissolution | CDTL KolkataCDSCO lab | Mar 2023 |
| Ridtas ? S (S(-)Amlodipine Tablets I.P.) | Batch RT220619Mfg Aug 2022 · Exp Jul 2024 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Dec 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.